Genetic overlaps in mental retardation, autism and schizophrenia

Monographs in Human Genetics

Volumn 18, Issue , 2010, Pages 126-136

  Kooy, R F ^a   Van Der Aa, N ^a   Vandeweyer, G ^a   Reyniers, E ^a   Rooms, L ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865303848     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000287602     Document Type: Article

References (61)

1. Luckasson R, Borthwick-Duffy S, Buntinx W H E, Coulter DL, Craig PM, et al: Mental retardation: definition, classification, and systems of supports, 10th ed. (American Association on Mental Retardation, Washington, DC, 2002).
2. Winnepenninckx B, Rooms L, Kooy RF: Mental retardation: a review of the genetic causes. Brit J Dev Disabil 2003;49:29-44. (Pubitemid 36231706)
3. American Psychiatric Association: Diagnostic and statistical manual of mental disorders DSM-IV-TR, 4th ed., text revision (American Psychiatric Association, Washington DC, 2000).
4. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T: Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368:210-215. (Pubitemid 44037796)
5. Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 2005;162:1133-1141. (Pubitemid 40770696)
6. Andreasen NC: Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995;346:477-481.
7. Kobrynski LJ, Sullivan KE: Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370:1443-1452. (Pubitemid 47576169)
8. Emanuel BS, Saitta SC: From microscopes to microarrays: dissecting recurrent chromosomal rearrangements. Nat Rev Genet 2007;8:869-883. (Pubitemid 47609084)
9. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, et al: Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 2006;103:7729-7734.
10. Koolen DA, Pfundt R, De Leeuw N, Hehir-Kwa JY, Nillesen WM, et al: Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat 2009;30:283-292.
11. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477-488.
12. Williams NM, O'Donovan MC, Owen MJ: Chromosome 22 deletion syndrome and schizophrenia. Int Rev Neurobiol 2006;73:1-27. (Pubitemid 44218794)
13. Stone JL, O'Donovan MC, Gurling H, Kirov GK, Blackwood DH, et al: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008;455:237-241.
14. Xu B, Roos JL, Levy S, Van Rensburg EJ, Gogos JA, Karayiorgou M: Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008;40:880-885. (Pubitemid 351913650)
15. Emanuel BS: Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements. Dev Disabil Res Rev 2008;14:11-18. (Pubitemid 351716518)
16. Sahoo T, Bacino CA, German JR, Shaw CA, Bird LM, et al: Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotypephenotype correlations. Eur J Hum Genet 2007;15:943-949. (Pubitemid 47308470)
17. D'Hulst C, Kooy RF: Fragile X syndrome: from molecular genetics to therapy. J Med Genet 2009;46:577-584.
18. Bendavid C, Dubourg C, Pasquier L, Gicquel I, Le Gallou S, et al: MLPA screening reveals novel subtelomeric rearrangements in holoprosencephaly. Hum Mutat 2007;28:1189-1197. (Pubitemid 350250383)
19. Cook Jr EH, Lindgren V, Leventhal BL, Courchesne R, Lincoln A, et al: Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997;60:928-934. (Pubitemid 27146502)
20. Sharp AJ, Mefford HC, Li K, Baker C, Skinner C, et al: A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008;40:322-328. (Pubitemid 351311774)
21. Van Bon B W M, Mefford HC, Menten B, Koolen DA, Sharp AJ, et al: Further delineation of the 15q13 microdeletion and duplication syndromes: A clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009;46:511-523.
22. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, et al: Large recurrent microdeletions associated with schizophrenia. Nature 2008;455:232-236.
23. Pagnamenta AT, Wing K, Akha ES, Knight SJ, Bolte S, et al: A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet 2009;17:687-692.
24. Klopocki E, Schulze H, Strauss G, Ott CE, Hall J, et al: Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopeniaabsent radius syndrome. Am J Hum Genet 2007;80:232-240. (Pubitemid 46175672)
25. Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, et al: Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008;359:1685-1699.
26. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al: Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007;39:319-328. (Pubitemid 46328498)
27. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008;320:539-543. (Pubitemid 351590668)
28. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, et al: Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358:667-675. (Pubitemid 351240746)
29. Ballif BC, Hornor SA, Jenkins E, Madan-Khetarpal S, Surti U, et al: Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 2007;39:1071-1073. (Pubitemid 47340655)
30. Kumar RA, Kara Mohamed S, Sudi J, Conrad DF, Brune C, et al: Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008;17:628-638. (Pubitemid 351201774)
31. Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, et al: Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 2008;63:1111-1117.
32. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, et al: Strong association of de novo copy number mutations with autism. Science 2007;316:445-449. (Pubitemid 46651493)
33. Ghebranious N, Giampietro PF, Wesbrook FP, Rezkalla SH: A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation. Am J Med Genet 2007;143 A: 1462-1471. (Pubitemid 47051025)
34. Chubykin AA, Liu X, Comoletti D, Tsigelny I, Taylor P, Sudhof TC: Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J Biol Chem 2005;280:22365-22374. (Pubitemid 40834299)
35. Feng J, Schroer R, Yan J, Song W, Yang C, et al: High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006;409:10-13. (Pubitemid 44585112)
36. Zahir FR, Baross A, Delaney AD, Eydoux P, Fernandes ND, et al: A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha. J Med Genet 2008;45:239-243. (Pubitemid 351518730)
37. Friedman JM, Baross A, Delaney AD, Ally A, Arbour L, et al: Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 2006;79:500-513. (Pubitemid 44384259)
38. Verkerk A J M H, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA: CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003;82:1-9. (Pubitemid 36693915)
39. Belloso JM, Bache I, Guitart M, Caballin MR, Halgren C, et al: Disruption of the CNTNAP2 gene in a t (7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur J Hum Genet 2007;15:711-713. (Pubitemid 46825060)
40. Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, et al: Recessive symptomatic focal epilepsy and mutant contactin-associated proteinlike 2. N Engl J Med 2006;354:1370-1377.
41. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, et al: Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008;82:150-159. (Pubitemid 351726082)
42. Bakkaloglu B, O'Roak BJ, Louvi A, Gupta AR, Abelson JF, et al: Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008;82:165-173. (Pubitemid 351735952)
43. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, et al: A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008;82:160-164. (Pubitemid 351726090)
44. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, Van der Vliet WA, et al: CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008;13:261-266. (Pubitemid 351272653)
45. Smith DI, Zhu Y, McAvoy S, Kuhn R: Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 2005;232:48-57. (Pubitemid 43053933)
46. Durkin SG, Ragland RL, Arlt MF, Mulle JG, Warren ST, Glover TW: Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci USA 2007;105:246-251.
47. Debacker K, Kooy RF: Fragile sites and human disease. Hum Mol Genet 2007;16:R150-R158.
48. Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, et al:15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009;41:160-162.
49. Riegel M, Baumer A, Jamar M, Delbecque K, Herens C, Verloes A, Schinzel A: Submicroscopic terminal deletions and duplications in retarded patients with unclassified malformation syndromes. Hum Genet 2001;109:286-294. (Pubitemid 32926923)
50. Fernandez T, Morgan T, Davis N, Klin A, Morris A, et al: Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet 2004;74:1286-1293. (Pubitemid 38669329)
51. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, et al: A functional genetic link between distinct developmental language disorders. N Engl J Med 2008;359:2337-2345.
52. Ramocki MB, Zoghbi HY: Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008;455:912-918.
53. Merla G, Howald C, Henrichsen CN, Lyle R, Wyss C, et al: Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. Am J Hum Genet 2006;79:332-341. (Pubitemid 44141831)
54. Van der Aa N, Rooms L, Van De Weyer G, Van Den Ende J, Reyniers E, et al: Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet 2009;52:94-100.
55. Woodberry KA, Giuliano AJ, Seidman LJ: Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry 2008;165:579-587. (Pubitemid 351705334)
56. Koolen DA, Pfundt R, De Leeuw N, Hehir-Kwa JY, Nillesen WM, et al: Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat 2009;30:283-292.
57. Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O: Disruption of the ProSAP2 gene in a t (12;22) (q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 2001;69:261-268. (Pubitemid 32695199)
58. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, et al: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007;39:25-27. (Pubitemid 46026497)
59. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477-88.
60. Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, et al: Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 2007;81:1289-97. (Pubitemid 350211458)
61. Sykes NH, Toma C, Wilson N, Volpi EV, Sousa I, et al: Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection. Eur J Hum Genet 2009;17:1347-1353.